v2.4.0.6
Business combinations Business combinations (Details) (USD $)
In Millions, unless otherwise specified
Jul. 05, 2012
Kai Pharmaceuticals [Member]
Jun. 12, 2012
Mustafa Nevzat Pharmaceuticals [Member]
Mar. 07, 2012
Micromet Inc [Member]
Mar. 07, 2012
Developed Technology [Member]
Micromet Inc [Member]
Jul. 05, 2012
In-Process Research and Development [Member]
Kai Pharmaceuticals [Member]
Mar. 07, 2012
In-Process Research and Development [Member]
Micromet Inc [Member]
Mar. 07, 2012
Contract Assets [Member]
Micromet Inc [Member]
Allocation of the total consideration to the acquisition date fair values of assets acquired and liabilities assumed              
Indefinite-lived intangible assets--IPR&D         $ 240 $ 440 $ 170
Finite-lived intangible assets   163   350      
Property, plant and equipment   100          
Trade receivables   79          
Inventories   52          
Goodwill 125 380 330        
Cash and marketable securities     154        
Deferred tax assets (liabilities), net (59) (45) (274)        
Other assets (liabilities), net 26 (52) (24)        
Total consideration $ 332 $ 677 $ 1,146